Intervention not reported
Attitudes or beliefs (Different measures used by the studies: perceived severity of vaccine‐preventable diseases, perceived necessity of vaccines, or a combination, on varying scales) Final time point (3 or 6 months post‐intervention) · parents of preschool‐aged children or expectant parents
1 finding from 1 review
Intervention not reported
Intention to vaccinate 1 to 7 (1 = definitely do not intend to vaccinate; 7 = definitely do intend to vaccinate) · parents of preschool‐aged children or expectant parents
1 finding from 1 review
Intervention not reported
Adverse effects (anxiety associated with intervention) · parents of preschool‐aged children or expectant parents
1 finding from 1 review
Intervention not reported
Parent experience of the intervention · parents of preschool‐aged children or expectant parents
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Cost (personnel, supplies, travel, office space, and orientation costs of intervention) · parents of preschool‐aged children or expectant parents
1 finding from 1 review
Intervention not reported
Acute exacerbations (number of exacerbations/person/year) · adults (> 18 years of age) with either COPD or recurrent acute exacerbations of chronic bronchitis
The intervention showed no clear difference in acute exacerbations (number of exacerbations/person/year) (low certainty).
1 finding from 1 review
Intervention not reported
Mortality (deaths during trial period) · adults (> 18 years of age) with either COPD or recurrent acute exacerbations of chronic bronchitis
It is very uncertain whether the intervention changes mortality (deaths during trial period) (very low certainty).
1 finding from 1 review
Intervention not reported
Carriage of NTHi Not meta‐analysed · adults (> 18 years of age) with either COPD or recurrent acute exacerbations of chronic bronchitis
1 finding from 1 review
no estimate extracted
Studies not reported
Very low
Intervention not reported
Antibiotic prescriptions (number of courses/person/year) **Corticosteroids not meta‐analysed · adults (> 18 years of age) with either COPD or recurrent acute exacerbations of chronic bronchitis
The intervention may leads to higher antibiotic prescriptions (number of courses/person/year)… (low certainty).
1 finding from 1 review
Intervention not reported
Hospital admissions (number of participants hospitalised during trial period) · adults (> 18 years of age) with either COPD or recurrent acute exacerbations of chronic bronchitis
1 finding from 1 review
no estimate extracted
Studies not reported
Moderate
Intervention not reported
Adverse events (number of adverse events/person/year) · adults (> 18 years of age) with either COPD or recurrent acute exacerbations of chronic bronchitis
The intervention showed no clear difference in adverse events (number of adverse events/person/year) (low certainty).
1 finding from 1 review
Intervention not reported
Quality of life Not meta‐analysed · adults (> 18 years of age) with either COPD or recurrent acute exacerbations of chronic bronchitis
1 finding from 1 review
no estimate extracted
Studies not reported
Very low
Intervention not reported
Influenza · People aged 60 or older living in long‐term care institutions
1 finding from 1 review
Intervention not reported
Lower respiratory tract infection · People aged 60 or older living in long‐term care institutions
1 finding from 1 review
Intervention not reported
Admission to hospital for respiratory illness · People aged 60 or older living in long‐term care institutions
1 finding from 1 review
Intervention not reported
Deaths from influenza or its complications · People aged 60 or older living in long‐term care institutions
1 finding from 1 review
Intervention not reported
Deaths from all causes · People aged 60 or older living in long‐term care institutions
1 finding from 1 review
Maternal death · Pregnant women aged 18 to 38 years and an estimated gestation of 20 to 36 weeks.
Viral influenza vaccine showed no clear difference in maternal death compared with control (moderate certainty).
1 finding from 1 review
Infant death (up to 175 days) · Pregnant women aged 18 to 38 years and an estimated gestation of 20 to 36 weeks.
Viral influenza vaccine showed no clear difference in infant death (up to 175 days) compared with control (moderate certainty).
1 finding from 1 review
Perinatal death (stillbirth + death in first week of life) · Pregnant women aged 18 to 38 years and an estimated gestation of 20 to 36 weeks.
Viral influenza vaccine showed no clear difference in perinatal death (stillbirth + death in first week of life) compared with control (moderate certainty).
1 finding from 1 review